Publications by authors named "Ronald Torres"

Claim this Profile
A
Alkaloid production and response to natural adverse conditions in : transcriptome analyses.
Seyed Mehdi Jazayeri, Mahtab Pooralinaghi, Yenny Torres-Navarrete, Byron Oviedo-Bayas, Ítalo Espinoza Guerra, Ronald Oswaldo Villamar Torres

BioTechnologia (Pozn)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delphi Project on the trends in Implant Dentistry in the COVID-19 era: Perspectives from Latin America.
Marco Antonio Alarcón, Ignacio Sanz-Sánchez, Jamil Awad Shibli, Alejandro Treviño Santos, Santiago Caram, Ronald Torres

Clin Oral Implants Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis .
Mark Renz, Ronald Torres, Philip J Dolan, Stephen J Tam, Jose R Tapia

Amyloid· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.
Jeffrey N Higaki, Avi Chakrabartty, Natalie J Galant, Kevin C Hadley, Bradley Hammerson, Ronald Torres

Amyloid· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.
Natalie J Galant, Antoinette Bugyei-Twum, Rishi Rakhit, Patrick Walsh, Simon Sharpe, Ronald Torres

Sci Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.
Natalie J Galant, Antoinette Bugyei-Twum, Rishi Rakhit, Patrick Walsh, Simon Sharpe, Ronald Torres

Sci Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis